Cost-cutting Agfa makes deals to expand healthcare range
This article was originally published in Clinica
Executive Summary
Agfa-Gevaert is to shed up to 4,000 jobs across the company - 18% of its workforce - as it implements cost-cutting measures. At the same time, it has announced two deals - the purchase of a minority share in MediVision Medical Imaging and all share capital of Mitra - as part of its strategy of becoming a "leading hospital imaging and informatics provider".
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.